Abstract
We have performed molecular modeling studies on four representative sigma receptor specific ligands, (+)haloperidol, (+)3-PPP, (+)pentazocine and progesterone, to develop a model for sigma receptor-ligand binding. The modeling studies have investigated the conformational and electrostatic properties of the ligands. Based on the complementarity of the conformational and electrostatic properties of the ligands, a model of binding has been proposed which shows that the four ligands can fit a common receptor sit. Unlike the binding model for haloperidol that was previously proposed by Manallack and Andrews, our model binds haloperidol in the gauche conformation. The first site binds the fluorophenyl group and the second site the lone pair of the piperidine nitrogen. This pharmacophore can be presented by (+)3-PPP and (+)pentazocine, but for progesterone the binding model requires the ring junction of the cyclohexenyl ring A and ring B to fit the fluorophenyl region, while the lone pair of the acetylcarbonyl oxygen at ring D emulates the nitrogen lone pair of the piperidine ring. Calculations were performed using RCG5 for generating conformations, molecular mechanics for calculating steric energies, quantum mechanical methods for generating charges, and ARCHEM for calculating electrostatic potentials on the Van der Waals surface.
Similar content being viewed by others
References
W.R. Martin, C.G. Ea, J.A. Thompson, R.E. Huppler and P.E. Gilbert, J. Pharmacol. Exp. Ther. 197 (1976) 517.
A.S. Keats and J. Telford, in:Molecular Modification in Drug Design: Advances in Chemistry, ed. R.F. Gould (Amer. Chem. Soc., Washington, DC, 1967), p. 170.
C.A. Haertzen, Psychopharmacologia 18 (1970) 366.
J.H. Jaffe and W.R. Martin, in:The Pharmacological Basis of Therapeutics, ed. A.G. Gilman, L.S. Goodman and A. Gilman (Macmillan, New York, 1980), p. 494.
S.R. Zukin and R.S. Zukin, Proc. Natl. Acad. Sci. 76 (1979) 5372;
J.P. Vincent, B. Kartalovski, P. Geneste, J.M. Kamenka and M. Lazdinski, Proc. Natl. Acad. Sci. 76 (1979) 4678;
TP. Su, J. Pharmacol. Exp. Ther. 223 (1982) 284;
R. Quirion, R. Chicheportiche, P.C. Contreras, K.M. Johnson, D. Lodges, S.W. Tam, J.H. Woods and S.R. Zukin, Trends in Neuroscience 10 (1987) 444.
E.H.F. Wong, J.A. Kemp, T. Priestley, A.R. Knight, G.N. Woodruff and L. Iversen, Proc. Natl. Acad. Sci. 83 (1986) 7104.
E.W. Weber, M. Sonders, m. Quarum, S. McLean, S. Pou and J.F.W. Keana, Proc. Natl. Acad. Sci. USA Neurobiology 83 (1986) 8784.
B.G. Campbell, D.H. Bobker, F.M. Leslie, I.N. Mefford and E. Weber, Eur. J. Pharmacol. 138 (1987) 447.
B.L. Largent, A.L. Gundlack and S.H. Snyder, Proc. Natl. Acad. Sci. USA 81 (1984) 4983.
D.T. Manallack, P.M. Beart and A.L. Gundlack, TIPS (1986)448.
B.L. Largent, H. Wikstrom, L. Gundlack and S.H. Snyder, Mol. Pharmacol. 32 (1987) 772.
B.L. Largent, H. Wikstrom, A.M. Snowman and S.H. Snyder, Eur. J. Pharmacol. 155 (1988) 345.
T.P. Su, E.D. London and J.H. Jaffe, Science 240 (1988) 219–221.
D.T. Manallack, M.G. Wong, M. Costa, P.R. Andrews and P.M. Beart, Mol. Pharmacol. 34 (1988) 863.
D.T. Mannallack and P.M. Beart, Eur. J. Chem. 144 (1987) 231.
T.P. Su, K. Shukla and T. Gund,Ciba Foundation Symp. 153 on Steroid and Neuronal Activity, ed. D.J. Chadwick (Wiley, Chichester, UK, 1990).
G.M. Smith and D.F. Veber, Biochem. Biophys. Res. Com. 134 (1986) 907.
N.L. Allinger and Y.H. Yuh, Quantum Chemistry Program Exchange, Program No. 395 (1980).
U. Burkert and N.L. Allinger,Molecular Mechanics, ACS Monograph 177 (1982), p. 1.
TRIPOS Associates, St. Louis, MO, USA.
Chemical Design, Oxford, UK.
ARCHEM: M. Hermsmeier and T.M. Gund, J. Mol. Graphics 7 (1989) 150–156.
C.E. Spivak, T.M. Gund, R.F. Liang and J.A. Waters, Eur. J. Pharmacol. 120 (1986) 127;
J.A. Waters, C.E. Spivak, M. Hermsmeier, J.S. Yadav, R.F. Liang and T.M. Gund, J. Med. Chem. 31 (1988) 545;
J.A. Waters, C.E. Spivak, M. Hermsmeier, J.S. Yadav, W.C. Shang and T.M. Gund, J. Med. Chem., 32 (1989) 529;
Review: T.M. Gund and P.H. Gund,Molecular Structures and Energetics, Vol. 4, ed. J. Liebman and A. Greenberg (VCH Publ., 1986), p. 319.
M.J.S. Dewar, University of Texas, Houston, TX, MOPAC program available from the Quantum Chemistry Program Exchange.
P. Politzer,Chemical Applications of Atomic and Molecular Electrostatic Potentials, ed. P. Politzer and D.G. Truhbar Plenum, New York, 1981), p. 1.
J.S. Binkely, R.A. Whiteside, R. Kirshnan, R. Seeger, DJ. Defrees, H.B. Schlegel, S. Topiol, L.R. Kahn and J.A. Pople, Gaussian 80, QCPE (1980), Bull. 2 (1982) 17.
U.C. Singh and P. Kollman, Gaussian 80, CUSF QCPE, Program.
J.S. Yadav, M. Hermsmeier and T. Gund, Int. J. Quant. Chem. Quant. Biol. Symp. 16 (1989) 101.
D. Taylor, Bristol-Myers Pharmaceutical Corp. private communication.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gund, T.M., Shukla, K. & Su, TP. Molecular modeling of sigma receptor ligands: A model of binding based on conformational and electrostatic considerations. J Math Chem 8, 309–325 (1991). https://doi.org/10.1007/BF01166945
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01166945